Gautam Sharma, MD, DM,a Venkatakrishnan Ramakumar, MD, DM,b Mohd Sharique, MS C,c Rohit Bhatia, MD, DM, DNB, d Nitish Naik, MD, DM,b Sriloy Mohanty, BNYS, c Aman Agarwal, MSC ,c Mohini Meti, MS C,e Akriti Shukla, BNYS, b Siddharthan Deepti, MD, DM,a Raghav Bansal, MD, DM,a Anunay Gupta, MD, DM,f A. Shaheer Ahmed, MD, DM,f R.M. Pandey, P HD, g Rajiv Narang, MD, DM, b Sundeep Mishra, MD, DM, b Anita Saxena, MD, DM, b Rajnish Juneja, MD, DM, b on behalf of the LIVE-Yoga Investigators
doi : 10.1016/j.jacep.2021.09.007
Volume 8, Issue 2, February 2022, Pages 141-149
This study aims to determine the impact of yoga as an adjunct to standard therapy versus standard therapy alone on the symptomatic burden in patients with recurrent vasovagal syncope (VVS).
Satish R. Raj, MD, MSCI, a,b Robert S. Sheldon, MD, PH D
doi : 10.1016/j.jacep.2021.11.006
Volume 8, Issue 2, February 2022, Pages 150-151
Varun Malik, BM EDS CI, MBBS, Adrian D. Elliott, PHD, Gijo Thomas, PHD, Ricardo S. Mishima, MD, PHD, Bradley Pitman, CCDS, Melissa E. Middeldorp, P HD, John L. Fitzgerald, MBBS, Glenn D. Young, MBBS, Kurt C. Roberts-Thomson, MBBS, PHD, Leonard F. Arnolda, MBBS, PH D, Dennis H. Lau, MBBS, PHD, Prashanthan Sanders, MBBS, PHD
doi : 10.1016/j.jacep.2021.10.010
Volume 8, Issue 2, February 2022, Pages 152-164
This study sought to evaluate the role of cardiac afferent reflexes in atrial fibrillation (AF).
Peter Hanna, MD, P HD, a Olujimi A. Ajijola, MD, P HD
doi : 10.1016/j.jacep.2022.01.013
Volume 8, Issue 2, February 2022, Pages 165-167
Takamitsu Takagi, MD, a Nicolas Derval, MD,a Thomas Pambrun, MD, a Yosuke Nakatani, MD,a Clémentine André, MD, a F. Daniel Ramirez, MD,a Takashi Nakashima, MD,a Philipp Krisai, MD,a Tsukasa Kamakura, MD,a Xavier Pineau, MS C, b Romain Tixier, MD,a Remi Chauvel, MD, a Ghassen Cheniti, MD,a Josselin Duchateau, MD, a Frédéric Sacher, MD,a Mélèze Hocini, MD,a Michel Haïssaguerre, MD,a Pierre Jaïs, MD,a Hubert Cochet, MDa
doi : 10.1016/j.jacep.2021.09.020
Volume 8, Issue 2, February 2022, Pages 168-178
This study sought to introduce a computed tomography (CT) protocol for optimal planning of vein of Marshall (VOM) catheterization.
Michael Ghannam, MD, Aman Chugh, MD
doi : 10.1016/j.jacep.2021.12.004
Volume 8, Issue 2, February 2022, Pages 179-181
Alessandro Capucci, MD, a Jorge A. Wong, MD, MPH,b Michael R. Gold, MD, P HD, c John Boehmer, MD,d Rezwan Ahmed, PH D, e Brian Kwan, MS, e Pramodsingh H. Thakur, PHD, e Yi Zhang, PHD, e Paul W. Jones, MS, e Jeffrey S. Healey, MD, MSC
doi : 10.1016/j.jacep.2021.09.015
Volume 8, Issue 2, February 2022, Pages 182-193
This study sought to investigate the temporal association between changes in physiologic heart failure (HF) sensors, atrial fibrillation (AF) progression, and clinical HF in patients with cardiac resynchronization therapy implantable defibrillators (CRT-D) designed to monitor AF and HF daily.
Joseph E. Marine, MD, Eunice Yang, MD
doi : 10.1016/j.jacep.2021.10.009
Volume 8, Issue 2, February 2022, Pages 194-196
Mohit K. Turagam, MD,a Petr Neuzil, MD, PH D, b Pavel Hala, MD,b Tomas Mraz, MD, b Srinivas R. Dukkipati, MD,a Vivek Y. Reddy, MD a
doi : 10.1016/j.jacep.2021.10.001
Volume 8, Issue 2, February 2022, Pages 197-207
This is a first report of the safety and 1-year outcomes of left atrial appendage closure (LAAC) using a novel foam-based conformable device, guided by intracardiac echocardiography (ICE).
Lucas V.A. Boersma, MD, PHD a
doi : 10.1016/j.jacep.2022.01.014
Volume 8, Issue 2, February 2022, Pages 208-210
Niraj Varma, MD, P HD, a Jian-An Wang, MD,b Aparna Jaswal, MD,c Kamal K. Sethi, MD, d Yusuke Kondo, MD,e Boyoung Joung, MD, f Dale Yoo, MD, g Angelo Auricchio, MD, PHD, h Jagmeet P. Singh, MD, PHD, i Kwangdeok Lee, PH D, j Michael R. Gold, MD, PHD
doi : 10.1016/j.jacep.2021.09.012
Volume 8, Issue 2, February 2022, Pages 211-221
The purpose of this study was to test the hypotheses that cardiac resynchronization therapy (CRT) efficacy differed among Asians compared with non-Asian populations, differed between QRS duration (QRSd) ranges 120-149 and ≥150 ms, and was influenced by height in the multinational ADVANCE CRT trial.
Varun Sundaram, MD, P HD, a Judith A. Mackall, MD
doi : 10.1016/j.jacep.2021.11.010
Volume 8, Issue 2, February 2022, Pages 222-224
Michele Orini, PHD, a,b, * Andreas Seraphim, MBBS, a,b, * Adam Graham, P HD, b Anish Bhuva, P HD, a,c Ernesto Zacur, PH D, d Peter Kellman, PH D, e Richard Schilling, MD,b Ross Hunter, P HD, b Mehul Dhinoja, MD, b Malcolm C. Finlay, PHD, b Syed Ahsan, MD,b Anthony W. Chow, MD, b James C. Moon, MD, a,c Pier D. Lambiase, PHD, a,b,y Charlotte Manisty, P HD a,c,y
doi : 10.1016/j.jacep.2021.10.002
Volume 8, Issue 2, February 2022, Pages 225-235
The purpose of this study was to assess the performance and limitations of low-voltage zones (LVZ) localization by optimized late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) scar imaging in patients with cardiac implantable electronic devices (CIEDs).
Haris M. Haqqani, MBBS(H ONS), PHD
doi : 10.1016/j.jacep.2021.11.009
Volume 8, Issue 2, February 2022, Pages 236-238
Robert Sheldon, MD, P HD, a Mario Talajic, MD, b Anthony Tang, MD,c Giuliano Becker, MD,d Vidal Essebag, MD, PHD, e Omar Sultan, MD, f Adrian Baranchuk, MD,g Debbie Ritchie, MN, a Carlos Morillo, MD, a Andrew Krahn, MD, h Michele Brignole, MD,i Braden Manns, MD, MS C,a Connor Maxey, BS C,a Satish R. Raj, MD, MSCI, a on behalf of the SPRITELY Investigators
doi : 10.1016/j.jacep.2021.10.003
Volume 8, Issue 2, February 2022, Pages 239-248
Fred M. Kusumoto, MD
doi : 10.1016/j.jacep.2021.10.008
Volume 8, Issue 2, February 2022, Pages 249-250
Eoin Donnellan, MDy Muzna Hussain, MDy Wael Jaber, MD Divyang R. Patel, MD Mohamed Kanj, MD Oussama Wazni, MD Mazen Hanna, MD *Patrick Collier, MD, PhD
doi : 10.1016/j.jacep.2021.11.016
Volume 8, Issue 2, February 2022, Pages 251-253
B. Hygriv Rao, MD Vyshnavi Gowlikar, PharmDSudhindra Vooturi, PhD David G. Benditt, MD H. Nagraj Rao, MD Mohandas Surath, MD
doi : 10.1016/j.jacep.2021.12.007
Volume 8, Issue 2, February 2022, Pages 253-254
Michifumi Tokuda, MD, PhD Seigo Yamashita, MD, PhD Mika Kato, MD, PhD Hidenori Sato, MD Hirotsuna Oseto, MD Masaaki Yokoyama, MD Kenichi Tokutake, MD, PhDRyohsuke Narui, MD, PhD Michihiro Yoshimura, MD, PhD Teiichi Yamane, MD, PhD
doi : 10.1016/j.jacep.2021.12.012
Volume 8, Issue 2, February 2022, Pages 255-257
Travis D. Richardson, MD William G. Stevenson, MD
doi : 10.1016/j.jacep.2021.11.020
Volume 8, Issue 2, February 2022, Page 257
William H. Perucki, MD Jeffrey J. Smietana, MD Edmond M. Cronin, MB BCh, BAO *Isaac R. Whitman, MD
doi : 10.1016/j.jacep.2021.12.015
Volume 8, Issue 2, February 2022, Pages 258-259
Jalaj Garg, MD Jayaprakash Shenthar, MD *Dhanunjaya Lakkireddy, MD
doi : 10.1016/j.jacep.2022.01.010
Volume 8, Issue 2, February 2022, Pages 259-260
Bastian Klemens Bauer, MD, a, * Claudia Meier, MD,b, * Michael Bietenbeck, PHD, b Philipp Sebastian Lange, MD,a Lars Eckardt, MD,a,y Ali Yilmaz, MD
doi : 10.1016/j.jacep.2021.11.017
Volume 8, Issue 2, February 2022, Pages 261-274
The possibilities of cardiovascular magnetic resonance (CMR) imaging for myocardial tissue characterization and catheter ablation guidance are accompanied by some fictional concepts. In this review, we present the available facts about CMR-guided catheter ablation procedures as well as promising, however unproven, theoretical concepts.
Rithika Thirumal, MD, a Ilan S. Wittstein, MD, b Hugh Calkins, MD, b Deeptankar DeMazumder, MD, PHD
doi : 10.1016/j.jacep.2021.10.006
Volume 8, Issue 2, February 2022, Pages 275-276
Tiberio M. Frisoli, MD,a, * Michael Chiang, MBBS, MD,a, * Marvin H. Eng, MD,b Pedro E. Gonzalez, MD, a Trevor Szymanski, MD,c Pedro A. Villablanca, MD,a Brian O’Neill, MD,a James C. Lee, MD,a Dee Dee Wang, MD,a William W. O’Neill, MD
doi : 10.1016/j.jacep.2021.11.015
Volume 8, Issue 2, February 2022, Pages 277-279
Bruce S. Stambler, MD, interviews Kenneth A. Ellenbogen, MD
doi : 10.1016/j.jacep.2021.11.003
Volume 8, Issue 2, February 2022, Pages 280.e1-280.e9
Do you want to add Medilib to your home screen?